^99mTc-sestamibi and ¹⁸F-fluorodeoxyglucose imaging in patients with cardiogenic shock: A pilot study.

ABSTRACT:

Background

Whether perfusion/metabolism imaging differs between matched ST-segment elevation myocardial infarction (STEMI) patients with and without cardiogenic shock (CS) remains unknown.

Methods

Seventeen STEMI patients with CS (13 men, 60 ± 12 years) and 16 matched STEMI patients without CS (15 men, 54 ± 15 years) were prospectively recruited. All patients underwent baseline ^99mTc-sestamibi/¹⁸F-fluorodeoxyglucose (FDG) imaging and echocardiography 6 ± 2 days post-infarction. Nine patients with CS and seven without CS had repeated imaging 98 ± 7 days post-infarction. The total perfusion deficit (TPD) and total FDG uptake deficit (TFD) were calculated to assess the percentages of impaired perfusion and metabolism over the left ventricle. Patients were

SUBMITTER: Hua C 

PROVIDER: S-EPMC9678924 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature